Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.66 |
Signal Transduction | R-HSA-162582 | 1.78 |
Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 9.28 |
Metabolism of carbohydrates | R-HSA-71387 | 4.93 |
Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 7.34 |
Glycosaminoglycan metabolism | R-HSA-1630316 | 6.04 |
HS-GAG degradation | R-HSA-2024096 | 8.52 |
Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 7.77 |
Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.66 |
Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 7.2 |
HS-GAG biosynthesis | R-HSA-2022928 | 8.03 |
Extracellular matrix organization | R-HSA-1474244 | 4.91 |
Metabolism | R-HSA-1430728 | 2.34 |
A tetrasaccharide linker sequence is required for GAG synthesis | R-HSA-1971475 | 8.28 |
Retinoid metabolism and transport | R-HSA-975634 | 7.59 |
Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.1 |
Syndecan interactions | R-HSA-3000170 | 8.23 |
Diseases of glycosylation | R-HSA-3781865 | 6.89 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 9.28 |
Disease | R-HSA-1643685 | 3.33 |
Visual phototransduction | R-HSA-2187338 | 6.44 |